All tenders
75N93021C00035
Rapid Point of Care Tests for Anti-TB Drug Quantification
National Institutes of Health · United States
This tender closed on Friday, March 15, 2024. Browse open opportunities
Time Left to Bid
Closed
ClosedOtherFederal
Basic information
- Reference number
- 75N93021C00035
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- Rapid Point of Care Tests for Anti-TB Drug Quantification
- Source
- USASpending (Federal)
- Source ID
- usa-75N93021C00035
Details
- Location
- United States
Summary
Procurement of advanced point-of-care diagnostic technology for simultaneously quantifying anti-tuberculosis drug concentrations in patient blood. Focuses on improving TB treatment monitoring and patient management.
Description
RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD. Awarded to: ZYMERON CORPORATION Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2021/08/12 12:00:00 AM UTC
- Closing date
- 2024/03/15 12:00:00 AM UTC
Estimated value
$1.3M USD
Classification
Normalized category
Other